Apoptosis induction and potent antiestrogen receptor-negative breast cancer activity in vivo by a retinoid antagonist

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4607-4610

  Fanjul, Andrea N ^a,b   Piedrafita, F Javier ^b   Al Shamma, H ^a   Pfahl, Magnus ^a,b  

^a MAXIA Pharmaceuticals Inc   (United States)

^b SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ANTIESTROGEN; ANTINEOPLASTIC AGENT; BROXURIDINE; CD 2674; DNA; ESTROGEN RECEPTOR; MX 781; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; SR 11302; SR 11335; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASES; ETHERS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; RECEPTORS, ESTROGEN; RETINOIDS; TUMOR CELLS, CULTURED;

EID: 0032532371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lu, X-P., Fanjul, A. N., Picard, N., Pfahl, M., Rungta, D., Nared-Hood, K., Carter, B., Piedrafita, F. J., Tang, S., Fabbrizio, E., and Pfahl, M. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med., 3: 686-690, 1997.
2. Bischoff, E. D., Gottardis, M. M., Moon, T. E., Heyman, R. A., and Lamph, W. W. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma. Cancer Research. 58: 479-484. 1998.
3. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schultz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and R. Evans. The nuclear receptor superfamily: the second decade. Cell, 83: 835-839, 1995.
4. Pfahl, M., Apfel, R., Bendik, I., Fanjul, A., Graupner, G., Lee, M-O., La-Vista, N., Lu, X-P., Piedrafita, F. J., Ortiz, M. A., Salben, G., and Zhang, X-K. Nuclear retinoid receptors and their mechanism of action. Vitam. Horm., 49: 327-382, 1994.
5. Sporn, M. B., Roberts, A. B., and Goodman, D. S. (eds.). The Retinoids: Biology, Chemistry, and Medicine, 2nd ed. New York: Raven Press, Ltd., 1994.
6. Fanjul, A. N., Bouterfa, H., Dawson, M. I., and Pfahl, M. Potential role for retinoic acid receptor-γ in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Research, 56: 1571-1577, 1995.
7. Fanjul, A. N., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., Dawson, M. I., and Pfahl, M. A novel class of retinoids with selective anti-AP-1 activity exhibit anti-proliferative activity. Nature (Lond.), 372: 107-111, 1994.
8. Lee, M-O., Dawson, M. I., Picard, N., Hobbs, P. D., and Pfahl, M. A novel class of retinoids antagonists and their mechanism of action. J. Biol. Chem., 271: 11897-11903, 1996.
9. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
10. Graupner, G., Malle, G., Maignan, J., Lange, G., Prunieras, M., and Pfahl, M. 6′-Substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligand. Biochem. Biophys. Res. Commun., 179: 1554-1561, 1991.
11. Lehmann, J. M., Jong, L., Fanjul, A., Cameron, J. F., Lu, X-P., Haefner, P., Dawson, M. L, and Pfahl, M. Retinoids selective for retinoid X receptor response pathways. Science (Washington DC), 258: 1944-1946, 1992.
12. Pfahl, M. Retinoids: concepts for separation of desirable and undesirable side effects in the treatment or prevention of cancer. In: Vedeckis, W. V. (ed.), Hormones and Cancer, pp. 127-146. Boston: Birkhauser, 1996.
13. Piedrafita, F. J., and Pfahl, M. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol. Cell. Biol., 17: 6348-6358, 1997.
14. Fanjul, A. N., Delia, D., Pierotti, M. A., Rideout, D., Qiu, J., and Pfahl, M. 4-hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem., 271: 22441-22446, 1996.
15. Kumar, S. ICE-like proteases in apoptosis. Trends Biochem. Sci., 20: 198-202, 1995.
16. Martin, S. J., and Green, D. R. Protease activation during apoptosis: death by a thousand cuts? Cell, 82: 349-352, 1995.
17. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T-T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammmalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
18. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J-L., Schroter, M., Scafftdi, C., Krammer, P.H., Peter, M. E., and Tschopp, J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (Lond.), 386: 517-521, 1997.
19. Henkart, P. A. ICE family proteases: mediators of all apoptotic cell death? Immunity, 4: 195-201, 1996.
20. Hsu, H., Xiong, J., and Goeddel, D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κ B activation. Cell, 81: 495-504, 1995.